1796.TWO GeneFerm Biotechnology Co Ltd

Healthcare Pharmaceuticals Taiwan OTC Exchange
26.65 TWD
Close of Nov 6, 2026
24.00 51.70
Market cap
TWD 1.10B
P/E
63.5x
P/B
1.39x
ROE
-1.1%
Dividend yield
2.66%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 1796.TWO undervalued?

Graham number
Price26.65
Graham value13.46
Premium98.1%

1796.TWO trades 98.1% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

GeneFerm Biotechnology Co Ltd fundamental analysis

No fundamental analysis for GeneFerm Biotechnology Co Ltd yet.

GeneFerm Biotechnology Co Ltd stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About GeneFerm Biotechnology Co Ltd

GeneFerm Biotechnology Co., Ltd. develops, manufactures, and sells fermented health products in Taiwan and internationally. The company provides microbial fermentation products, including fungi, bacteria, lactic acid bacteria, yeast, algae, etc.; bio fermented ingredients, such as nattomena, natto fermented powder, red yeast rice fermented powder, antrodia cinnamomea mycelia powder, cordyceps, reishi mycelia, phellinus linteus mycelia powder, armillaria mellea mycelia powder…

Full company profile